News
- Author:
- Michele G. Sullivan
Publish date: February 12, 2018
DALLAS – In the SUN trial, researchers were looking for four pregnancy complications, including oligohydramnios.
News
- Author:
- Michele G. Sullivan
Publish date: February 12, 2018
DALLAS – Women with operative delivery and episiotomy saw a modest benefit.
News
- Author:
- Michele G. Sullivan
Publish date: February 9, 2018
DALLAS – A cost-minimization analysis of the 2016 PARENT trial, comparing betamethasone with placebo.
News
- Author:
- Michele G. Sullivan
Publish date: February 9, 2018
Procedural side effects resolve spontaneously.
News
- Author:
- Michele G. Sullivan
Publish date: February 8, 2018
DALLAS – The AFFIRM study intervention resulted in significant increases in labor induction and cesarean sections.
News
- Author:
- Michele G. Sullivan
Publish date: February 6, 2018
DALLAS – A team at Cornell examined amniotic fluid samples for five potential biomarkers, finding that two may have utility.
News
- Author:
- Michele G. Sullivan
Publish date: February 3, 2018
DALLAS – Ibuprofen doesn’t exacerbate hypertension in women with preeclampsia.
News
- Author:
- Michele G. Sullivan
Publish date: February 2, 2018
DALLAS – New study findings are at odds with the American College of Obstetricians and Gynecologists’ “Choosing Wisely” campaign.
Video
- Author:
- Michele G. Sullivan
Publish date: February 1, 2018
Colonoscopy screenings should commence at age 40 years for most, but at age 30 years for CF patients with lung transplants.
News
- Author:
- Michele G. Sullivan
Publish date: January 25, 2018
A full report in the New England Journal of Medicine details the latest ntiamyloid failure.
News
- Author:
- Michele G. Sullivan
Publish date: January 22, 2018
Significant differences were noted in the risk of progression between patients with IgM MGUS and those with non-IgM MGUS.
News
- Author:
- Michele G. Sullivan
Publish date: January 18, 2018
Vaccination before DMARD initiation or while on a drug holiday might be a good idea.
News
- Author:
- Michele G. Sullivan
Publish date: January 16, 2018
Pathogenic TP53 variants could hold the key to identifying ALL patients with a poor prognosis.
News
- Author:
- Michele G. Sullivan
Publish date: January 11, 2018
NLRP3 is activated in 46% of African Americans, and once activated it leads to chronically increased levels of inflammatory cytokines.
News
- Author:
- Michele G. Sullivan
Publish date: January 10, 2018
Allelic variants of the gene had either pathogenic or protective effects.
